Optimise drug manufacturing processes to cut costs

The Operational Excellence Congress is for pharmaceutical manufacturing managers to share perspectives on optimising manufacturing processes to cut costs, boost productivity, and maintain compliance

The Operational Excellence (OpX) Congress is for pharmaceutical manufacturing Industry leaders to share perspectives on optimising drug manufacturing processes to cut costs, boost productivity, and maintain compliance.

As the industry shifts focus from blockbuster revenues to "trimming the fat", makers of pharmaceutical and biotech products are seeking ways to boost efficiency and streamline operations.

Leading companies are finding that manufacturing and production offer tremendous opportunities to cut costs, reduce time, and achieve overall excellence.

These opportunities are more numerous - and more significant - than many have realised.

That's why, on January 30-31 in Philadelphia, pharmaceutical executives are invited to take part in an extraordinary opportunity to convene as an industry and discuss strategies for achieving Operational Excellence.

Organised by the Centre for Business Intelligence, the OpX Congress will go beyond theory to provide practical insights and case studies.

Hear 11 Industry Perspectives and Case Studies on Operational Excellence, including.

* Merck addresses how to implement a sustainable platform for quality assurance and system operational excellence.

* Eli Lilly illustrates how they merged automation and IT systems, bridging the gap between IT and manufacturing.

* TAP Pharmaceuticals shows how to leverage an automated, technology-driven continuous production system.

* Bristol-Myers Squibb shares a case study on developing a robust statistical process control solution that reduces quality, yield and cycle time variations.

* Genentech presents their operational excellence deployment strategy and shares some of their LEAN successes.

* sanofi-aventis provides metrics for measuring manufacturing capabilities, tools for improvement and strategies for cutting the fat.

* Johnson and Johnson discusses the tools used in their "Process Excellence" programme, including Six Sigma, Value Stream Mapping, Five Ss, Failure Mode and Effect Analysis, Lean Manufacturing and Project Charters.

* Pfizer reveals strategies for minimising variation and predicting process performance by leveraging PAT technology.

You can also choose from two pre-conference workshops on employing next-generation Six Sigma techniques, and leveraging information management systems to automate and streamline manufacturing processes.

First 'Employ Next Generation Six Sigma Techniques'.

Six Sigma is a results-driven approach that has been successfully employed by leading companies, such as General Electric, Motorola and Ford Motor Company.

Pharmaceutical manufacturing is primed to reap extraordinary benefits from applying next generation Six Sigma methodologies.

As competitive pressures and focus on profit mount, adopting a concrete process improvement strategy can improve time to market, efficiency in the production of drugs and can streamline manufacturing processes.

It is estimated that Six Sigma projects in manufacturing can save over $300,000 on an annual basis.

This workshop illustrates Six Sigma techniques and shows you how to leverage next generation Six Sigma for substantial savings in your pharmaceutical manufacturing.

Second 'Leverage Information Management Systems to Automate and Streamline Manufacturing Processes'.

The pharmaceutical industry has a record of making good use of technology in product development.

Further down the line, in its manufacturing facilities, the spread of computer technology has stalled at machine-level data collection for tracking basic processing information.

Limited automation, electronic record keeping and information collection contribute to the pharmaceutical industry's poor manufacturing efficiency record and to a costly and increasingly crippling regulatory reporting infrastructure.

Pharmaceutical manufacturing is plagued with poor process understanding and control, inefficient, voluminous, paper-based production workflow and chronic uncertainty of demand in the consumer market.

These factors are a recipe for supply-chain inefficiency that has yielded average inventory turns of three to five versus 50 for world-class manufacturers in other industries.

In this in-depth workshop, learn how automation and information technology can support regulatory requirements and can achieve the business objectives of pharmaceutical manufacturing.

For a full convention programme please consult the website.

Back to top